Metagenomi is laying of 25% of its staff while switching up leadership. Elsewhere, Ovid announced a CEO succession plan and Cogent Biosciences and Galecto saw their shares skyrocket.

Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple Myeloma Thirty-two unique studies (4,790 patients) were included. All were health ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

In this blog we will explore relevant issues pertaining to patients with complex corneas — irregular astigmatism, keratoconus, corneal trauma or post-corneal surgery — who represent approximately 12% ...

Abstract: Commit messages concisely describe code changes in natural language and are important for software maintenance. Several approaches have been proposed to automatically generate commit ...